Advertisement
UK markets closed
  • FTSE 100

    7,895.85
    +18.80 (+0.24%)
     
  • FTSE 250

    19,391.30
    -59.37 (-0.31%)
     
  • AIM

    745.67
    +0.38 (+0.05%)
     
  • GBP/EUR

    1.1607
    -0.0076 (-0.65%)
     
  • GBP/USD

    1.2370
    -0.0068 (-0.55%)
     
  • Bitcoin GBP

    51,343.84
    +379.18 (+0.74%)
     
  • CMC Crypto 200

    1,372.94
    +60.32 (+4.59%)
     
  • S&P 500

    4,967.23
    -43.89 (-0.88%)
     
  • DOW

    37,986.40
    +211.02 (+0.56%)
     
  • CRUDE OIL

    83.24
    +0.51 (+0.62%)
     
  • GOLD FUTURES

    2,406.70
    +8.70 (+0.36%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • HANG SENG

    16,224.14
    -161.73 (-0.99%)
     
  • DAX

    17,737.36
    -100.04 (-0.56%)
     
  • CAC 40

    8,022.41
    -0.85 (-0.01%)
     

BUZZ-Top of the Street: BTG, Integrated oil and refining, Solvay, UDG Healthcare

A round-up of notable broker activity this morning from Europe's top-ranked* analysts:

** BTG (Frankfurt: 908827 - news) : Deutsche Bank (IOB: 0H7D.IL - news) says that guidance and performance for key unit Interventional Medicine were softer than its expectations and sees the pharma business at risk of going ex-growth; broker cuts stock to "hold"

** Barclays (LSE: BARC.L - news) reviews ratings and PTs (Other OTC: PTSH - news) among integrated oil and refining stocks to factor in some of the profitability that higher prices are generating, with its top picks being still BP , Royal Dutch Shell (LSE: 0LN9.L - news) and Total (LSE: 524773.L - news)

Galp Energia's risks are now skewed to the downside after its 12 pct run in the last three months, per broker; Barclays cuts the stock to "underweight"

ADVERTISEMENT

Broker upgrades Eni (LSE: 0N9S.L - news) to "equal weight", saying that the higher oil price environment benefits the Italian company more than most other companies under its coverage

** Solvay (LSE: 0NZR.L - news) : UBS (LSE: 0QNR.L - news) says that the recovery in aerospace and oil & gas lifts EBITDA growth and free cash flow but adds that soda ash is a drag; ups to "neutral"

INITIATIONS AND REINSTATEMENTS

** UDG Healthcare (LSE: UDG.L - news) : "We believe the stock is fully valued and already bakes in some of the benefits of future M&A," says Barclays, starting with "equal weight"

(*Analyst rankings from Thomson Reuters StarMine. Scale is from 1-star to 5-star with 5 being best. Analysts ranked on earnings accuracy as well as relative performance of recommendations over trailing 12-month & 24-month periods.)